Toggle menu

LAVAS Study

Start date:
Historic
End date:
June 2014
Co-ordinated by:
NHS Lothian

Lactate, Arterial and Venous Agreement in Sepsis – LAVAS trial

Aim

To determine whether an agreement between peripheral venous and arterial lactate exists in patients presenting to an Emergency Department with sepsis.

Trial Design

A prospective observational study in a consecutive sample of eligible and consented patients in the Royal Infirmary of Edinburgh

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected sepsis

Chief Investigator

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Local PI

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Research Team

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.

Read more

TARGET-CTCA Trial

EHA - Epidemiological analysis for the Hereditary Angioedema Disease is an international, multicentre, epidemiological study that aims to explore the feasibility of a new Dried Blood Spot (DBS) filtercard-based screening algorithm and thereby the prevalence of the Hereditary Angioedema.

Read more

EHA Study

EHA - Epidemiological analysis for the Hereditary Angioedema Disease

The Emergency Medicine Annotated Bioresource Consortium (EM-ABC): A pilot and feasability programme

Read more

EMERGE Biobank

Developing a bioresource for all emergency presentations